PATERNA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 7.918
EU - Europa 4.477
AS - Asia 3.415
SA - Sud America 497
AF - Africa 98
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.415
Nazione #
US - Stati Uniti d'America 7.846
SG - Singapore 1.265
RU - Federazione Russa 989
CN - Cina 900
IT - Italia 743
UA - Ucraina 638
FI - Finlandia 565
DE - Germania 407
BR - Brasile 402
HK - Hong Kong 396
VN - Vietnam 311
PL - Polonia 270
FR - Francia 225
IE - Irlanda 225
GB - Regno Unito 210
JP - Giappone 169
SE - Svezia 84
KR - Corea 71
IN - India 63
BD - Bangladesh 46
AR - Argentina 37
CA - Canada 32
NL - Olanda 30
MX - Messico 29
IQ - Iraq 28
TR - Turchia 28
PK - Pakistan 21
UZ - Uzbekistan 21
ZA - Sudafrica 21
CI - Costa d'Avorio 20
VE - Venezuela 16
BE - Belgio 15
RO - Romania 15
EC - Ecuador 12
EG - Egitto 12
ES - Italia 12
MA - Marocco 12
NP - Nepal 12
PY - Paraguay 12
IR - Iran 11
AT - Austria 10
CH - Svizzera 10
KE - Kenya 9
CO - Colombia 8
ID - Indonesia 7
KZ - Kazakistan 7
SA - Arabia Saudita 7
AL - Albania 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
LB - Libano 6
PH - Filippine 6
SN - Senegal 6
TN - Tunisia 6
AZ - Azerbaigian 5
DZ - Algeria 5
JO - Giordania 5
MY - Malesia 5
CL - Cile 4
IL - Israele 4
NZ - Nuova Zelanda 4
AE - Emirati Arabi Uniti 3
ET - Etiopia 3
EU - Europa 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
UY - Uruguay 3
AU - Australia 2
BH - Bahrain 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
LT - Lituania 2
MD - Moldavia 2
NG - Nigeria 2
PE - Perù 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 16.415
Città #
Ashburn 941
Singapore 879
Fairfield 856
Houston 539
Woodbridge 493
Chandler 451
Wilmington 418
Hong Kong 387
San Jose 383
Jacksonville 351
Ann Arbor 328
Seattle 314
Cambridge 284
Dublin 225
Zgierz 202
Palermo 178
Santa Clara 161
Moscow 158
Frankfurt am Main 157
Medford 156
Des Moines 150
Beijing 135
Tokyo 134
Nanjing 132
Ho Chi Minh City 105
Princeton 102
Tulsa 92
Lauterbourg 90
Altamura 87
Los Angeles 82
Hanoi 80
Boardman 78
San Diego 68
Hefei 66
New York 64
Dallas 60
Lawrence 59
Kraków 55
Helsinki 52
Council Bluffs 47
Dearborn 47
Buffalo 46
Nanchang 43
Shenyang 43
Chicago 37
Milan 37
Hebei 33
Seongnam 32
Venice 29
Jinan 25
Munich 25
Changsha 24
São Paulo 23
Jiaxing 21
London 21
Abidjan 20
Orem 20
San Mateo 20
Verona 20
Kumar 18
Tianjin 18
Amsterdam 17
Haiphong 17
Ludwigshafen am Rhein 16
Ningbo 16
Turku 16
Kunming 15
Tashkent 15
The Dalles 15
Brussels 14
City of London 14
Da Nang 14
Guangzhou 14
Cardiff 13
Atlanta 12
Baghdad 12
Belo Horizonte 12
Columbus 12
Phoenix 12
Stockholm 11
Warsaw 11
Zhengzhou 11
Auburn Hills 10
Falls Church 10
Guarulhos 10
Rio de Janeiro 10
Rome 10
Salt Lake City 10
Düsseldorf 9
Izmir 9
Norwalk 9
Nuremberg 9
Ottawa 9
San Paolo di Civitate 9
Taizhou 9
Tehran 9
Cairo 8
Chennai 8
Dhaka 8
Johannesburg 8
Totale 10.654
Nome #
Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose–Response Curves in Worsening Refractory Congestive Heart Failure 338
Fever of unclear origin and cytopenia because of acute splenic sequestration in a young immunocompetent carrier of Beta-globin mutation for hb valletta. 299
Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction 296
Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction 294
Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects 283
Changes in Brain Natriuretic Peptide Levels and Bioelectrical Impedance Measurements After Treatment With High-Dose Furosemide and Hypertonic Saline Solution Versus High-Dose Furosemide Alone in Refractory Congestive Heart Failure A Double-Blind Study 264
Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary findings. 263
Medium-Term Effects of Bisoprolol Administration on Renal Hemodynamics and Function in Mild to Moderate Essential Hypertension 241
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 232
Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings 219
Combination of a high bolus dose of tirofiban with half-dose thrombolytics for the treatment of subacute stent thrombosis 217
The pathophysiology of acute heart failure: the key role of fluid accumulation 216
Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure. 207
Water and Sodium in Heart Failure: A Spotlight on Congestion. 207
The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. 205
Role of segmental and whole body bioelectrical impedance analysis in acute heart failure diagnosis. 200
A new option in measuring bioimpedance in congestive heart failure 198
Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT. 197
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 195
Immediate versus delayed facilitated percutaneous coronary intervention. A pilot study 193
Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function 192
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 192
Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? 190
Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects 189
Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur) 189
Relationship between ACE-DD polymorphism and diastolic performance in healthy subjects 186
Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. 185
EFFECT OF CANREONATE PLUS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN-CONVERTNG ENZYME INHIBITORS AOLNE ON SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION 182
ASSOCIAZIONE TRA HS-PCR E DIMENSIONI DELL'ATRIO SINISTRO IN IPERTESI MAI TRATTATI IN RITMO SINUSALE 181
Are BNP plasma levels useful in heart failure diagnosis each time? A dyspneic patient with anasarca 181
Short-term walking physical training and changes in body hydration status, B-type natriuretic peptide and C-reactive protein levels in compensated congestive heart failure. 181
Impact of "Off-Label" Use of Ivabradine on Exercise Capacity, Gas Exchange, Functional Class, Quality of Life, and Neurohormonal Modulation in Patients With Ischemic Chronic Heart Failure 181
cardiovascular effects of I/D angiotensin converting enzyme gene polymorphismin healty subjects: Findings after follow-up of six years 179
Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects 179
An unusual presentation of massive pulmonary embolism mimicking septal acute myocardial inferction treated with tenecteplase 177
High dose torasemide is equivalent to high-dose furosemide with Hypertnic saline in the treatment of refractory congestive heart failure 175
CARDIOPULMONARY EXERCISE TESTING IN PATIENTS WITH CHRONIC HEART FAILURE: PROGNOSTIC COMPARISON FROM PEAK VO2 AND VE/VCO2 SLOPE. 174
Wet BNP, fluid and hemodynamic status at discharge in Acute Heart Failure. 172
Intravenous high dose furosemide plus small volume of hypertonic saline solution (HSS) versus seriated paracentesis in treatment of refractory ascites. 170
Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings. 170
Changes in natriuretic peptides and cytokines plasma levels in patients with heart failure, after high dose of furosemide plus small volume saline solution (HSS) and after an acute saline loading 165
Bioelectrical Impedance Analysis and prediction of hospitalization for heart failure in ambulatory patients with symptomatic left ventricular dysfunction: preliminary data 164
Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). 163
Ultrasonography NAFLD subclinical carotid atherosclerosis and inflammatory markers in patients with and without metabolic syndome. 162
A case of febrile illness and multiple pulmonary embolism in a young woman acting hormonal contrapceptives. 161
delayed facilitated percutaneous coronary intervention versus immediate in reperfused stemi 160
Long-Term Effects of Dietary Sodium Intake on Cytokines and Neurohormonal Activation in Patients With Recently Compensated Congestive Heart Failure 160
evaluation of BNP plasma levels and bioelectrical impedance analysis (BIA) in decompensated heart failure. A double blind study 159
Long-term effect on immune-inflammatory and neuro-endocrine pathways of a new therapeutic strategy for advanced heart failure 158
Long-term effects on immune-inflammatory and neuro-endocrine pathways of a new therapeutic strategy for advanced heart failure 157
Is there any novelty on the horizon of heart failure management in internal medicine? The evaluation of body fluid accumulation 157
Effect of physiscal training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure 156
One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study. 155
Novel strategies: challenge loop diuretics and sodium management in heart failure--part II. 154
Bed-side inferior vena cava diameter and mean arterial pressure predict long-term mortality in hospitalized patients with heart failure: 36 months of follow-up 154
Bioelectrical impedance parameters versus BNP testing to differentiate decompensated heart failure from chronic obstructive pulmonary disease. 151
Two-dimensional echocardiographic evaluation of left ventricular ejection fraction by the ellipsoid single-plane algorithm: a reliable method for assessing low or very low ejection fraction values? 151
Evaluation of regional haemodynamics and alterations of vascu¬lar wall of the lower limbs in hypertensive subjects 149
Early ultrasonographic markers of atherosclerosis in adul white recent onset of primary hypertension and familial history of cardiovascular event 146
Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity. 145
Intravenous high dose furosemide plus small volume of hypertonic saline solution (HSS) versus seriated paracentesis in treatment of refractory ascites: a pilot study 144
acute coronary syndrome following large-volume paracentesis. Case report and pathophysiology 143
Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction. 141
Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment. 141
Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure 141
Whole-body and segmental bioelectrical impedance analyisis to predict rehospitalization due to worsening of congestive heart failure in anbulatory patients 139
Time to ferry heart failure onto new shores: the need to effectively customize long-term therapy. 139
Biolectrical impedance analysis as a new diagnostic tool for heart failure diagnosis in parimary care: preliminary data 138
impedance analyisis to predict rehospitalization due to worsening of congestive heart failure in anbulatory patients 138
One year atorvastatin treatment in patients with familial hypercholesterolemia: effect on CRP and fibrinogen 136
Relationship between non-invasive measurement of endothelial function and familial hystory of cardiovascular event in hypertensives subjects of recent onset. 134
One year atorvastatin treatment in patients with familial hypercholesterolrmia: effects on CRP and fibrinogen 134
Small-volume hypertonic saline solution and high-dosage furosemide in the treatment of refractory congestive heart failure. A pilot study 133
Role of segmental and whole body bioelecttrical impedance analisys (BIA) in acute heart failure diagnosis 132
Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure 132
heart failure, after high dose of furosemide plus small volume saline solution (HSS) and after an acute saline loading 131
Thrombolysis for massive pulmonary embolism in pregnancy: a case report. 129
Echocardiographic PCWP evaluation in decompensated heart failure: relationship with B-type natriuretic peptide and bioelectrical impedance anaysis. 128
Is there a link between liver steatosis, carotid atherosclerosis and C-reactive protein in metabolic and non-metabolic patients? 128
Cardiovascular Effects of I/D angiotension converting enzyme gene polymorphism in heathy subjects 127
Delayed facilitated percutaneous coronary intervention is better than immediate in reperfused myocardial infarction 125
The challenge of the volume status assessment in heart failure. 125
Clinical-anamnestic and instrumental data in outpatients suffering from venous disease 124
One year atorvastatin treatment in patients with familial hypercholesterolemia: effects on CRP and fibrinogen 123
Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. 121
Use of bivalirudin for heparin-induced thrombocytopaenia after thrombolysis in massive pulmonary embolism: a case report. 121
Safwty of bioelectrical impedance analysis inevaluation of patient with liver chirrosis and relation with severity of disease 118
Sensitivity, Specifity and Predictive value of the Echocardiography and Troponin- T test combination in patients with non-St Elevetion Acute Coronary Syndromes 117
Non alcoholic liver steatosis asymptomatic carotid atherosclerosis and C-reactive protein in diabetic and non-diabetic patients. 116
Unusual case of recurrent pyrexia of unknown origin and cytopenia due to acute splenic sequestration crisis in a young patient with splenomegaly and beta-globin mutation for Hb-Valletta 115
Sodium: an ld emery or a new friend for advanced failured patients? 113
Relationship between ultrasonographic measurements of inferior vena cava and bioelectrical impedance analysis parameters in patients with decompensated congestive heart failure. 112
Evaluation of BNP levels and bioelectrical impedance measurements after a novel therapy of refractory congestive heart failure 112
DIAGNOSTIC VALUE OF SEGMENTAL AND WHOLE BODY IMPEDANCE ANALYSIS IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH ACUTE DYSPNEA 112
Intavenous high dose furosemide plus small volume of hypertonic saline solutions (HSS) versus seriated paracentesis in treatment of refractory ascites: a pilot study 109
Safety of bioelectrical impedance analysis inevaluation of patient with liver chirrosis and relation with severity of disease. 109
OMEGA 3 FATTY ACIDS LEVEL: REDUCTION RISK OF SUDDEN DEATH FROM MYOCARDIAL INFARCTION 102
Steatosi epatica non-alcolica e aterosclerosi carotidea asintomatica in soggetti con e senza sindrome metabolica: uno studio caso-controllo 97
Obesity and iron deficiency anemia as risk factors for asymptomatic bacteriur 95
The dry weight maintainance, estimated with bioelectrical impedance analysis, predicts freedom from congestion and post-discharge clinical outcome in ambulatory heart failure despite previous class III-IV symptoms 87
Totale 16.477
Categoria #
all - tutte 53.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021263 0 0 0 0 0 0 0 0 0 0 133 130
2021/20221.068 36 296 34 32 33 18 79 45 121 112 62 200
2022/20231.322 137 242 9 121 164 227 110 94 142 5 53 18
2023/2024506 27 81 29 50 45 114 36 29 6 14 3 72
2024/20251.655 39 207 115 134 38 52 100 96 99 162 220 393
2025/20265.343 425 98 300 359 386 818 688 592 455 1.057 165 0
Totale 16.638